However, given the ambiguous role of PTEN in neurodegeneration, we suspect the consequences of PERK inhibition on PTEN/PI3K/AKT axis could be complex and either result in protection or toxicity depending on the proteopathy model being studied. The gene discussed is PTEN; the disease is proteostasis deficiencies.